Literature DB >> 2400634

Protein kinase C pseudosubstrate prototope: structure-function relationships.

C House1, B E Kemp.   

Abstract

A structure-function study of the protein kinase C (PK-C) pseudosubstrate sequence (R19FARK-GALRQKNV31) has been undertaken. The role of specific residues was investigated using an alanine substitution scan. Arg-22 was the most important determinant in the inhibitor sequence, since substitution of this residue by alanine gave a 600-fold increase in the IC50 value to 81 +/- 9 microM. Substitutions of other basic residue also increased the IC50, 5-, 11- and 24-fold for the Ala-19, Ala-23 and Ala-27 substitutions, respectively. The importance of basic residues in determining the potency of the pseudosubstrate peptide reflects the requirements for these residues in peptide substrate phosphorylation. The residues Gly-24, Leu-26 and Gln-28 were also important for pseudosubstrate inhibitor potency. The large difference in the IC50 value for the [A22]PK-C(19-31) peptide makes it a valuable control in studies employing the pseudosubstrate peptide to explore functional roles of PK-C.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2400634     DOI: 10.1016/0898-6568(90)90022-3

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  10 in total

1.  Multisite dephosphorylation and desensitization of conventional protein kinase C isotypes.

Authors:  G Hansra; P Garcia-Paramio; C Prevostel; R D Whelan; F Bornancin; P J Parker
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

Review 2.  Protein Kinase C as Regulator of Vascular Smooth Muscle Function and Potential Target in Vascular Disorders.

Authors:  H C Ringvold; R A Khalil
Journal:  Adv Pharmacol       Date:  2016-07-18

Review 3.  Protein kinase C: perfectly balanced.

Authors:  Alexandra C Newton
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-04       Impact factor: 8.250

Review 4.  Protein kinase C isoenzymes: divergence in signal transduction?

Authors:  H Hug; T F Sarre
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

5.  Protein Kinase C Quality Control by Phosphatase PHLPP1 Unveils Loss-of-Function Mechanism in Cancer.

Authors:  Timothy R Baffi; An-Angela N Van; Wei Zhao; Gordon B Mills; Alexandra C Newton
Journal:  Mol Cell       Date:  2019-03-20       Impact factor: 17.970

6.  Inhibition of protein kinase C catalytic activity by additional regions within the human protein kinase Calpha-regulatory domain lying outside of the pseudosubstrate sequence.

Authors:  Angie F Kirwan; Ashley C Bibby; Thierry Mvilongo; Heimo Riedel; Thomas Burke; Sherri Z Millis; Amadeo M Parissenti
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

7.  Identification, activity, and structural studies of peptides incorporating the phorbol ester-binding domain of protein kinase C.

Authors:  P A Wender; K Irie; B L Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

Review 8.  Evolving mechanisms of vascular smooth muscle contraction highlight key targets in vascular disease.

Authors:  Zhongwei Liu; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2018-02-13       Impact factor: 5.858

9.  Peptide substrates for Rho-associated kinase 2 (Rho-kinase 2/ROCK2).

Authors:  Jeong-Hun Kang; Daisuke Asai; Akira Tsuchiya; Takeshi Mori; Takuro Niidome; Yoshiki Katayama
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

Review 10.  PKC and PKN in heart disease.

Authors:  Valeria Marrocco; Julius Bogomolovas; Elisabeth Ehler; Cristobal G Dos Remedios; Jiayu Yu; Chen Gao; Stephan Lange
Journal:  J Mol Cell Cardiol       Date:  2019-02-08       Impact factor: 5.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.